Quantcast

Latest Implanted cardiac resynchronization device Stories

2015-02-02 20:21:46

MARLBOROUGH, Mass., Feb. 2, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the launch and first U.S.

2014-11-11 12:27:08

LONDON, Nov. 11, 2014 /PRNewswire/ -- Global Market Watch:Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.1 billion by 2016.

2014-07-07 08:26:07

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-06-24 10:06:57

Cardiac resynchronization therapy plus defibrillator implantation (CRT-D) sometimes helps women with heart failure more than men, although women are less likely to receive CRT-D than men.

2014-06-09 08:30:45

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-04-15 16:28:34

NATICK, Mass., April 15, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed

2014-04-02 16:30:55

LONDON, April 2, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

2014-04-02 16:30:42

LONDON, April 2, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:


Word of the Day
dittany
  • An aromatic woolly plant (Origanum dictamnus) native to Crete, formerly believed to have magical powers.
The word 'dittany' may come from the name of Mount Diktē in Crete, where it was supposed to grow.
Related